The National Institutes of Health will spend about $1.1 billion this year on research to prevent and treat opioid addiction, NIH Director Francis Collins, M.D., announced today. The Helping to End Addiction Long-term Initiative will study patients after acute onset of musculoskeletal pain and after surgery to identify biomarkers that might predict those more likely to transition from acute to chronic pain; genetic and social factors that put patients at risk for opioid misuse and addiction; and best practices for pain management using nondrug and integrated therapies for specific pain conditions. It also will pursue public-private partnerships to develop new non-addictive pain medicines; build a clinical trials network to allow multiple compounds to be tested simultaneously for effectiveness; research additional treatment options for addiction and neonatal opioid withdrawal syndrome; and test prevention and treatment options in health care and criminal justice settings in states with the highest opioid misuse and overdose rates.

Related News Articles

Headline
The Health Resources and Services Administration yesterday awarded 120 organizations, including hospitals, $200,000 each to develop community partnerships and…
Headline
Laws that allow pharmacists to dispense the opioid antidote naloxone without a physician’s prescription are associated with a sharp reduction in fatal opioid-…
Headline
The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid…
Perspective
Investing in our country’s health infrastructure is the right move to make.
Headline
The AHA yesterday announced support for the Opioid Workforce Act of 2019, bipartisan legislation to reduce the nation’s shortage of opioid treatment providers…
Headline
The National Academy of Medicine Action Collaborative on Countering the U.S. Opioid Epidemic, of which the AHA is a sponsor, held a two-day meeting this week…